Management of Gastric Antral Adenocarcinoma
For gastric antral adenocarcinoma, the management depends critically on clinical stage: very early disease (T1a, well-differentiated, <2cm, non-ulcerated) can be treated with endoscopic submucosal dissection (ESD), while stage IB and above requires perioperative chemotherapy (preferably FLOT or ECF regimen for 3 cycles pre- and post-operatively) combined with D2 gastrectomy with examination of at least 15-16 lymph nodes. 1, 2
Mandatory Initial Steps
All cases must be discussed at a multidisciplinary team meeting before any treatment decision, including surgeons, medical and radiation oncologists, gastroenterologists, radiologists, and pathologists. 3, 1, 2 When local expertise is unavailable, refer to an expert center before proceeding. 1
Complete Staging Workup
The following staging investigations are necessary before treatment planning:
- Physical examination with complete blood count to assess for iron deficiency anemia 1, 2
- Liver and renal function tests to determine appropriate therapeutic options 1, 2
- Upper endoscopy with biopsy reviewed by an experienced pathologist, documenting tumor size, description, location, distance from gastroesophageal junction, and any extension 3, 4
- Contrast-enhanced CT of chest, abdomen, and pelvis using multidetector CT scanners with 5mm slices 1, 2, 4
- Endoscopic ultrasound (EUS) for accurate T and N staging in potentially operable tumors, though note that EUS is less useful specifically for antral tumors 3, 5, 6, 1
- Diagnostic laparoscopy with peritoneal washings to exclude occult peritoneal metastases in all patients with cT3-T4 lesions or those considered potentially resectable 3, 7, 1, 4
- HER2 testing on biopsy specimens for molecular biomarker assessment 1, 2
Common pitfall: Omitting laparoscopy in potentially resectable cases may miss peritoneal metastases not detected on imaging in 10-20% of cases. 1
Treatment Algorithm Based on Stage
Very Early Disease (T1a)
Endoscopic submucosal dissection (ESD) is the preferred curative treatment when ALL of the following criteria are met: 8, 1
- Confined to mucosa (T1a)
- Well or moderately differentiated (G1-2)
- Non-ulcerated lesion
- ≤2 cm in diameter
- No lymphovascular invasion
ESD is preferred over endoscopic mucosal resection (EMR) for lesions >10mm due to higher complete resection rates. 1 This procedure should only be performed in experienced medical centers. 8
Post-endoscopic resection surveillance includes first follow-up endoscopy at 6 months, then annual endoscopy thereafter, as recurrence risk is 10-20%. 1
Critical caveat: Never attempt endoscopic resection for diffuse-type (signet ring cell) gastric cancer regardless of size or depth, as these require upfront surgery. 1
Localized Disease (Stage IB and Above)
The standard approach is perioperative chemotherapy combined with surgical resection. 1, 2
Perioperative Chemotherapy
Preferred regimen: Triplet chemotherapy with fluoropyrimidine + platinum compound + docetaxel (FLOT regimen) for 3 cycles pre-operatively and 3 cycles post-operatively. 1
Alternative regimen: ECF (epirubicin 50 mg/m², cisplatin 60 mg/m², continuous 5-FU 200 mg/m²/day) for 3 cycles pre- and post-operatively, which improves 5-year survival from 23% to 36.3%. 5, 2 ECX (substituting capecitabine for 5-FU) is commonly used as an alternative. 2
The perioperative approach has been adopted as standard of care in most of the UK and parts of Europe based on the UK MRC randomized trial. 5
Surgical Resection
D2 gastrectomy is the standard surgical approach for resectable gastric cancer classified as cT1N+ and cT2-4N-/+. 8, 2, 9, 10
For antral tumors specifically, distal gastrectomy is appropriate with adequate resection margins of ≥3 cm for Borrmann I-II tumors and ≥5 cm for Borrmann III-IV tumors. 2
D2 lymphadenectomy involves removal of perigastric (D1) and second-tier lymph nodes along the named vessels of the celiac axis. 7, 2, 10 At least 15-16 lymph nodes must be examined pathologically for adequate staging, with optimal examination of at least 25 lymph nodes. 3, 5, 7, 2, 10
Splenectomy is not routinely recommended unless the tumor directly involves the spleen, as it increases postoperative complications without survival benefit. 2
Critical pitfall: Inadequate lymph node evaluation (fewer than 15 nodes) leads to understaging and suboptimal treatment planning. 2
Post-operative Chemotherapy
Complete the remaining 3 cycles of the same preoperative chemotherapy regimen if R0 resection was achieved, for a total of 6 cycles perioperatively. 7, 1
Locally Advanced Unresectable Disease
Concurrent chemoradiotherapy is recommended for patients with unresectable locally advanced gastric cancer with good performance status. 2 Chemotherapy regimens used with radiation include capecitabine + paclitaxel, cisplatin + 5-FU/capecitabine, or oxaliplatin + 5-FU/capecitabine. 2
Re-evaluate for potential surgical resectability after treatment response. 2
Metastatic Disease (Stage IV)
Palliative chemotherapy is recommended for patients with stage IV disease and good performance status. 2
For HER2-positive disease: Trastuzumab plus fluoropyrimidine/capecitabine + cisplatin is the standard first-line therapy. 7
For HER2-negative disease: Cisplatin plus fluoropyrimidine-based regimens are first-line therapy. 7, 2
Special Considerations for Bulky Nodal Disease
Bulky nodal disease is potentially resectable if: 7
- Level 3 or 4 lymph nodes are NOT highly suspicious on imaging
- No invasion or encasement of major vascular structures
- No distant metastases or peritoneal seeding
For resectable bulky nodal disease, administer 2-3 cycles of combination chemotherapy before surgery, followed by D2 lymphadenectomy and completion of perioperative chemotherapy. 7
Key Pitfalls to Avoid
- Never skip laparoscopy for clinical stage IB-III disease, as occult peritoneal metastases change management in 10-20% of cases 1
- Never proceed with surgery before multidisciplinary team discussion 1, 2
- Never perform routine splenectomy as it increases complications without survival benefit 2
- Never accept inadequate lymph node harvest (<15 nodes) as it leads to understaging 2, 10